Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies
Clinical trial NCT05100823 · TERMINATED
Trial details
- NCT number
- NCT05100823
- Sponsor
- University Hospital, Montpellier
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2025-02-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.